How Is Telemedicine Being Used In Opioid And Other Substance Use Disorder Treatment?

被引:107
作者
Huskamp, Haiden A. [1 ]
Busch, Alisa B. [2 ,3 ]
Souza, Jeffrey [3 ]
Uscher-Pines, Lori [4 ]
Rose, Sherri [5 ]
Wilcock, Andrew [3 ]
Landon, Bruce E. [1 ]
Mehrotra, Ateev [6 ]
机构
[1] Harvard Med Sch, Dept Hlth Care Policy, Hlth Care Policy, Boston, MA 02115 USA
[2] Harvard Med Sch, McLean Hosp, Psychiat & Hlth Care Policy, Boston, MA 02115 USA
[3] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA
[4] RAND Corp, Arlington, VA USA
[5] Harvard Med Sch, Dept Hlth Care Policy, Biostat, Boston, MA 02115 USA
[6] Harvard Med Sch, Dept Hlth Care Policy, Hlth Care Policy & Med, Boston, MA 02115 USA
关键词
HEALTH; CARE;
D O I
10.1377/hlthaff.2018.05134
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Only a small proportion of people with a substance use disorder (SUD) receive treatment. The shortage of SUD treatment providers, particularly in rural areas, is an important driver of this treatment gap. Telemedicine could be a means of expanding access to treatment. However, several key regulatory and reimbursement barriers to greater use of telemedicine for SUD (tele-SUD) exist, and both Congress and the states are considering or have recently passed legislation to address them. To inform these efforts, we describe how tele-SUD is being used. Using claims data for 2010-17 from a large commercial insurer, we identified characteristics of tele-SUD users and examined how tele-SUD is being used in conjunction with in-person SUD care. Despite a rapid increase in tele-SUD over the study period, we found low use rates overall, particularly relative to the growth in telemental health. Tele-SUD is primarily used to complement in-person care and is disproportionately used by those with relatively severe SUD. Given the severity of the opioid epidemic, low rates of tele-SUD use represent a missed opportunity. As tele-SUD becomes more available, it will be important to monitor closely which tele-SUD delivery models are being used and their impact on access and outcomes.
引用
收藏
页码:1940 / 1947
页数:8
相关论文
共 21 条
[1]  
American Society of Addiction Medicine, 2018, TEST D KAN MD DFASAM
[2]  
[Anonymous], 2017, KEY SUBSTANCE USE ME
[3]  
[Anonymous], 2021, PAT MAN HYP SUBJ REC
[4]   Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers [J].
Arora, Sanjeev ;
Thornton, Karla ;
Murata, Glen ;
Deming, Paulina ;
Kalishman, Summers ;
Dion, Denise ;
Parish, Brooke ;
Burke, Thomas ;
Pak, Wesley ;
Dunkelberg, Jeffrey ;
Kistin, Martin ;
Brown, John ;
Jenkusky, Steven ;
Komaromy, Miriam ;
Qualls, Clifford .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (23) :2199-2207
[5]  
Barnett ML, 2018, DIFFUSION TELE UNPUB
[6]  
Barton C, 2018, TELEMEDICINE ADDICTI
[7]   Barriers and Facilitators to Substance Use Treatment in the Rural South: A Qualitative Study [J].
Browne, Teri ;
Priester, Mary Ann ;
Clone, Stephanie ;
Iachini, Aidyn ;
DeHart, Dana ;
Hock, Robert .
JOURNAL OF RURAL HEALTH, 2016, 32 (01) :92-101
[8]  
Centers for Disease Control and Prevention, OV DRUG OV EP NUMB
[9]   Usefulness of telepsychiatry: A critical evaluation of videoconferencing-based approaches [J].
Chakrabarti, Subho .
WORLD JOURNAL OF PSYCHIATRY, 2015, 5 (03) :286-304
[10]   The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting [J].
Eibl, Joseph K. ;
Gauthier, Graham ;
Pellegrini, David ;
Daiter, Jeffery ;
Varenbut, Michael ;
Hogenbirk, John C. ;
Marsh, David C. .
DRUG AND ALCOHOL DEPENDENCE, 2017, 176 :133-138